BioCardia, Inc. Earnings Per Share, Basic and Diluted
BioCardia, Inc. (BCDA) reported Earnings Per Share, Basic and Diluted of -$0.75 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-29
- BioCardia, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.20.
- BioCardia, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.16.
- BioCardia, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.20.
- BioCardia, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.18.
- BioCardia, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.75.
- BioCardia, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.48.
- BioCardia, Inc. earnings per share, basic and diluted for fiscal 2019 was -$2.61.
- BioCardia, Inc. earnings per share, basic and diluted for fiscal 2018 was -$3.28.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.57 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$0.75 10-K · filed 2022-03-29 | ||||
| 2021-09-30 | -$0.16 10-Q · filed 2021-11-10 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.54 10-Q · filed 2021-11-10 | -$0.76 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2021-06-30 | -$0.20 10-Q · filed 2021-08-12 | -$0.38 10-Q · filed 2021-08-12 | -$0.60 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.89 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2021-03-31 | -$0.18 10-Q · filed 2021-05-13 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.69 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2020-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.53 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$0.93 derived: net income ÷ weighted average shares · filed 2022-03-29 | -$1.48 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | -$0.30 10-Q · filed 2021-11-10 | -$0.73 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.33 10-Q · filed 2021-11-10 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||||
| 2020-06-30 | -$0.46 10-Q · filed 2021-08-12 | -$1.07 10-Q · filed 2021-08-12 | -$1.64 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.26 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||||
| 2020-03-31 | -$0.67 10-Q · filed 2021-05-13 | -$1.19 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$1.81 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.55 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||||
| 2019-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$1.14 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$1.88 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$2.61 10-K · filed 2021-03-30 | ||||
| 2019-09-30 | -$0.63 10-Q · filed 2020-11-10 | -$1.39 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$2.13 10-Q · filed 2020-11-10 | -$3.06 derived: net income ÷ weighted average shares · filed 2020-11-10 | ||||
| 2019-06-30 | -$0.77 10-Q · filed 2020-08-13 | -$1.53 10-Q · filed 2020-08-13 | -$2.48 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$3.31 derived: net income ÷ weighted average shares · filed 2020-11-10 | ||||
| 2019-03-31 | -$0.86 10-Q · filed 2020-05-15 | -$0.08 10-Q · filed 2019-05-15 | -$1.71 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$2.54 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$3.30 derived: net income ÷ weighted average shares · filed 2020-11-10 | |||
| 2018-12-31 | -$0.85 derived: net income ÷ weighted average shares · filed 2020-04-09 | -$1.68 derived: net income ÷ weighted average shares · filed 2020-04-09 | -$2.44 derived: net income ÷ weighted average shares · filed 2020-04-09 | -$3.28 10-K · filed 2020-04-09 | -$0.36 10-K · filed 2019-04-02 | |||
| 2018-09-30 | -$0.83 10-Q · filed 2019-11-19 | -$0.09 10-Q · filed 2018-11-08 | -$1.59 derived: net income ÷ weighted average shares · filed 2019-11-19 | -$2.43 10-Q · filed 2019-11-19 | -$0.27 10-Q · filed 2018-11-08 | $1.09 derived: net income ÷ weighted average shares · filed 2020-04-09 | ||
| 2018-06-30 | -$0.76 10-Q · filed 2019-08-14 | -$0.08 10-Q · filed 2018-08-09 | -$1.60 10-Q · filed 2019-08-14 | -$0.18 10-Q · filed 2018-08-09 | $0.56 derived: net income ÷ weighted average shares · filed 2020-04-09 | $3.16 derived: net income ÷ weighted average shares · filed 2020-04-09 | ||
| 2018-03-31 | -$0.09 10-Q · filed 2019-05-15 | $0.24 derived: net income ÷ weighted average shares · filed 2020-04-09 | $1.43 derived: net income ÷ weighted average shares · filed 2020-04-09 | -$3.05 derived: net income ÷ weighted average shares · filed 2020-04-09 | ||||
| 2017-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2020-04-09 | $0.22 derived: net income ÷ weighted average shares · filed 2020-04-09 | $1.34 derived: net income ÷ weighted average shares · filed 2020-04-09 | -$2.90 10-K · filed 2020-04-09 | -$0.32 10-K · filed 2018-03-16 | |||
| 2017-09-30 | -$0.08 10-Q · filed 2018-11-08 | -$0.16 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$0.23 10-Q · filed 2018-11-08 | -$0.35 derived: net income ÷ weighted average shares · filed 2019-04-02 | ||||
| 2017-06-30 | -$0.08 10-Q · filed 2018-08-09 | -$0.01 10-Q · filed 2017-08-14 | -$0.15 10-Q · filed 2018-08-09 | -$0.01 10-Q · filed 2017-08-14 | -$0.27 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$0.47 derived: net income ÷ weighted average shares · filed 2019-04-02 | ||
| 2017-03-31 | -$0.08 10-Q · filed 2018-05-10 | -$0.01 10-Q · filed 2017-05-11 | -$0.19 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$0.54 derived: net income ÷ weighted average shares · filed 2019-04-02 | |||
| 2016-12-31 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$0.45 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$0.54 derived: net income ÷ weighted average shares · filed 2019-04-02 | -$1.23 10-K · filed 2019-04-02 | -$0.10 10-K · filed 2017-03-30 | |||
| 2016-09-30 | -$2.06 10-Q · filed 2017-11-09 | $0.02 10-Q · filed 2016-10-17 | -$0.52 derived: net income ÷ weighted average shares · filed 2017-11-09 | -$4.26 10-Q · filed 2017-11-09 | $0.02 10-Q · filed 2016-10-17 | |||
| 2016-06-30 | -$0.11 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2016-08-02 | -$0.19 10-Q · filed 2017-08-14 | $0.00 10-Q · filed 2016-08-02 | ||||
| 2016-03-31 | -$0.08 10-Q · filed 2017-05-11 | $0.00 10-Q · filed 2016-05-03 | ||||||
| 2015-12-31 | -$4.29 10-K · filed 2018-03-16 | $0.00 10-K · filed 2016-03-25 | ||||||
| 2015-09-30 | $0.00 10-Q · filed 2016-10-17 | $0.00 10-Q · filed 2016-10-17 | ||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-02 | $0.00 10-Q · filed 2016-08-02 | ||||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-03 | |||||||
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 | |||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-10-29 | $0.00 10-Q · filed 2015-10-29 | ||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-12 | $0.00 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-03-24 | |||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-06 | $0.00 10-Q · filed 2014-08-06 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-24 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-01 | $0.00 10-Q · filed 2013-11-01 | ||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-07-26 | $0.00 10-Q · filed 2013-07-26 | ||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | |||||||
| 2011-12-31 | $0.04 10-K · filed 2013-03-22 | |||||||
| 2011-09-30 | $0.05 10-Q · filed 2012-11-08 | $0.00 10-Q · filed 2011-11-15 | $0.04 10-Q · filed 2012-11-08 | |||||
| 2011-06-30 | $0.05 10-Q · filed 2012-08-10 | $0.05 10-Q · filed 2012-08-10 | ||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$0.05 10-K · filed 2012-03-29 | |||||||
| 2010-09-30 | -$0.04 10-Q · filed 2011-11-15 | -$0.05 10-Q · filed 2011-11-15 | ||||||
| 2010-06-30 | -$0.01 10-Q/A · filed 2011-11-17 | -$0.01 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |